Neseritide therapy for the preservation of left ventricular function post anterior myocardial infarction.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Nov 2014
At a glance
- Drugs Nesiritide (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms BELIEVE-II
- 31 Aug 2018 Biomarkers information updated
- 08 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 24 Jan 2012 Planned end date changed from 1 Jan 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.